DETECTION OF FLUOROQUINOLONE-RESISTANT BACTERIA PRIOR TO TRANSRECTAL PROSTATE BIOPSY: ANALYSIS OF STOOL SAMPLES FACILITATES TARGETED PROPHYLAXIS

Conclusion: We found high numbers of fluoroquinolone-resistant E. coli in faeces collected prior to prostate biopsy. Thus, fluoroquinolones should not be used for prostate biopsy prophylaxis. We found no difference in the extent of quinolone-resistance in patients graded by age, prostate specific antigen level, or antibiotic use in the prior 6 months. In risky cases, faecal culture results may be used to choose appropriate prophylaxis.